🇺🇸 FDA

Intelligence Platform

Patents

Browse 5 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11197812

Cosmetic formulations for topical applications containing erythropoietin-derived molecules

ASC REGENITY LIMITED · Granted Tue Dec 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10912791

Compositions comprising antisense-encoded erythropoietin receptor and use thereof

The Board of Regents of the University of Texas System · Granted Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10456346

Cosmetic formulations for topical applications containing erythropoietin-derived molecules

ASC REGENITY LIMITED · Granted Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10233452

Compositions and methods for increasing erythropoietin (EPO) production

Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7300915

Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain

The Regents of the University of California · Granted Tue Nov 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted